Solara Active Pharma Sciences Ltd.(NSE:SOLARA)

Solara Active Pharma Sciences Ltd. engages in the manufacture and development of active pharmaceutical ingredient. Its products include NSAID, anaesthetic, analgesics, antiviral, retinod, anti-emetic, antimalrial, diuretic, muscle relaxant, antiallergics, antihypertensive, calcimimetic agent, anti sezure, antigout, cardiovascular, anti-infective, cough suppressant, anti-ulcerative, anesthetic, antiepileptic, antirheumatic, skin disorder, cardiovascular agent, aplha or beta antagonist, hyperphosphatamia, atypical antipsychotic, antineoplastic adjunct, anti psoriasis, barbiturate dervicative, treatment of overactive bladder, gastro-intestinal, atypical antipsychotic, antihyperlipidemic, antihelmintic, gastrointestinal, antibiotic, phenylalanine reducer, anticholetithic, and anti depressant. The company was founded on February 23, 2017 and is headquartered in Chennai, India.